Table 1.
patients | cytogenetic endpoint | ||||
---|---|---|---|---|---|
CA (%) | t(Ba)/cell | t(Ab)/cell | dic/cell | cj/cell | |
significantly increased cytogenetic effects | |||||
patient 1 | 52.7 | 0.317 | 0.385 | 0.336 | 1.377 |
patient 3 | 53.7 | 0.347 | 0.355 | 0.238 | 1.285 |
patient 7 | 54.7 | 0.353 | 0.264 | 0.259 | 1.209 |
patient 17 | 51.7 | 0.313 | 0.381 | 0.224 | 1.136 |
significantly reduced cytogenetic effects | |||||
patient 30 | 49.1 | 0.171 | 0.239 | 0.107 | 0.585 |
patient 36 | 30.8 | 0.149 | 0.097 | 0.144 | 0.533 |
patient 37 | 26.0 | 0.020 | 0.060 | 0.140 | 0.320 |
patient 41 | 27.5 | 0.183 | 0.174 | 0.174 | 0.642 |
CA%: percentage of cells containing structural aberrations
Italic: significant difference to mean value of patients